National Vision Holdings, Inc. (EYE) News
Filter EYE News Items
EYE News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
EYE News Highlights
- EYE's 30 day story count now stands at 27.
- Over the past 29 days, the trend for EYE's stories per day has been choppy and unclear. It has oscillated between 1 and 5.
- The most mentioned tickers in articles about EYE are BEAT, ABT and ACT.
Latest EYE News From Around the Web
Below are the latest news stories about National Vision Holdings Inc that investors may wish to consider to help them evaluate EYE as an investment opportunity.
National Vision Holdings, Inc. Announces Participation in the Morgan Stanley Virtual Global Consumer & Retail ConferenceDULUTH, Ga.--(BUSINESS WIRE)--National Vision Holdings, Inc. (NASDAQ: EYE) today announced the Company is scheduled to participate in a fireside chat at the Morgan Stanley Virtual Global Consumer & Retail Conference on Wednesday, December 1, 2021, at 10:15 a.m. Eastern Time. A live webcast of the presentation can be accessed on the Investors section of the Companys website at www.nationalvision.com/investors. The webcast will be archived and available on the website shortly after the eve |
National Vision Holdings, Inc. Increases Share Repurchase Authorization to $100 MillionDULUTH, Ga., November 29, 2021--National Vision Holdings, Inc. (NASDAQ: EYE) ("National Vision" or the "Company") today announced that its Board of Directors has authorized an increase by $50 million to $100 million in the Company’s share repurchase program. Since the original $50 million program was authorized on November 8, 2021, approximately 1.0 million shares have been repurchased for a total consideration of $48.4 million. |
Brokerages Anticipate National Vision Holdings, Inc. (NASDAQ:EYE) Will Announce Quarterly Sales of $459.45 MillionWall Street analysts expect National Vision Holdings, Inc. (NASDAQ:EYE) to post sales of $459.45 million for the current quarter, Zacks Investment Research reports. Two analysts have issued estimates for National Visions earnings. The highest sales estimate is $468.70 million and the lowest is $450.20 million. National Vision posted sales of $496.70 million during the same [] |
National Vision Holdings, Inc. (NASDAQ:EYE) Expected to Post Earnings of -$0.02 Per ShareEquities research analysts expect National Vision Holdings, Inc. (NASDAQ:EYE) to report earnings per share (EPS) of ($0.02) for the current quarter, Zacks Investment Research reports. Two analysts have made estimates for National Visions earnings. The lowest EPS estimate is ($0.05) and the highest is $0.01. National Vision posted earnings of $0.45 per share during the [] |
National Vision Announces 2021-2022 Scholarship Program, Focusing on Importance of Accessible Eye CareDULUTH, Ga., November 17, 2021--National Vision, Inc., the nation’s second largest optical retailer providing quality, affordable eye care and eyewear, announced today that its annual scholarship program is open for entries, giving eligible optometry students the chance to win up to $7,500, the largest scholarship amount yet for the program. |
Abbott (ABT) Scales to a 52-Week High: What's Driving It?Strong performance by the Diabetes Care and Diagnostics businesses is driving the top line for Abbott (ABT). |
Cardiovascular Systems (CSII) Business Down on COVID ResurgenceAccording to Cardiovascular Systems (CSII), the resurgence of COVID-19 and the related staffing shortages are disrupting referral patterns and having the largest impact on elective procedures. |
Walgreens (WBA), VillageMD Plan to Expand Into Tampa, FloridaWalgreens (WBA), VillageMD to open 20 new Village Medical at Walgreens primary care practices in the Tampa area to improve access to overall care for patients with chronic conditions. |
Here's Why You Should Add LabCorp (LH) to Your Portfolio NowInvestors are optimistic about LabCorp (LH) backed by consistent recovery across its businesses and raised 2021 guidance. |
Here's Why You Should Hold on to Teleflex (TFX) Stock for NowInvestors are optimistic about Teleflex (TFX) owing to better-than-anticipated results in the third quarter and strength in the Vascular business. |